- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medrad signs UltraGuide
Interventional CT represents a strategic opportunity for Medrad. The company has signed its second distribution agreement in three months, this one with Lakewood, CO-based UltraGuide, for products addressing this market segment.Medrad, a U.S. subsidiary
Interventional CT represents a strategic opportunity for Medrad. The company has signed its second distribution agreement in three months, this one with Lakewood, CO-based UltraGuide, for products addressing this market segment.
Medrad, a U.S. subsidiary of Schering, agreed in January to begin distributing UltraGuide's CT-Guide in the U.S. and France. The visual guidance system designed for minimally invasive CT procedures will be marketed along with SimpliCT, a CT guidance device manufactured by NeoRad. A distribution agreement for SimpliCT was signed in November. Interventional guidance is a natural extension of Medrad's product lines, according to the company, which provides MRI surface coils and power injectors for contrast-enhanced studies.
New Study Assesses Benefits of High-Resolution Photon-Counting for Computed Tomography Angiography
October 10th 2024Researchers found that ultra-high resolution photon-counting significantly enhanced visualization of small vessels and facilitated improved reduction of blooming artifacts for head and neck computed tomography angiography (CTA) scans.
Multicenter Study Identifies Key Factors Associated with Mammogram-Occult Ipsilateral Breast Cancer
October 9th 2024A symptomatic first breast cancer diagnosis, prevailing breast density at a second breast cancer diagnosis and trabecular thickening on surveillance mammography were linked to mammogram-occult ipsilateral breast cancer, according to new research.
